PHARMGEN SCIENCE

The current price of 004720 is 5120 KRW — it has decreased by 1.54% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange PHARMGEN SCIENCE stocks are traded under the ticker 004720.

004720 stock is 3.55% volatile and has beta coefficient of 0.57. Check out the list of the most volatile stocks — is PHARMGEN SCIENCE there?

Yes, you can track PHARMGEN SCIENCE financials in yearly and quarterly reports right on TradingView.

004720 stock has fallen by 5.19% compared to the previous week, the month change is a 8.57% fall, over the last year PHARMGEN SCIENCE has showed a 25.58% decrease.

004720 net income for the last quarter is ‪−321.13 M‬ KRW, while the quarter before that showed ‪−2.12 B‬ KRW of net income which accounts for 84.86% change. Track more PHARMGEN SCIENCE financial stats to get the full picture.

No, 004720 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 004720 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMGEN SCIENCE stock right from TradingView charts — choose your broker and connect to your account.

004720 reached its all-time high on Sep 14, 2012 with the price of 35700 KRW, and its all-time low was 2580 KRW and was reached on Nov 7, 2014.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 281.00 employees. See our rating of the largest employees — is PHARMGEN SCIENCE on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMGEN SCIENCE technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMGEN SCIENCE stock shows the strong sell signal. See more of PHARMGEN SCIENCE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMGEN SCIENCE EBITDA is ‪13.37 B‬ KRW, and current EBITDA margin is 8.02%. See more stats in PHARMGEN SCIENCE financial statements.